The demand for therapeutic plasma‐derived products poses a challenge to blood collection agencies (BCAs). In 2014–2015, the volume of plasma sent for fractionation met 17.7% of Quebec's needs for immunoglobulins.… Click to show full abstract
The demand for therapeutic plasma‐derived products poses a challenge to blood collection agencies (BCAs). In 2014–2015, the volume of plasma sent for fractionation met 17.7% of Quebec's needs for immunoglobulins. This article aims to offer an exploration of the paths blood donors follow in order to become plasma and platelet donors (PPDs).
               
Click one of the above tabs to view related content.